These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 18804534

  • 1. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.
    Huizinga R, Gerritsen W, Heijmans N, Amor S.
    Neurobiol Dis; 2008 Dec; 32(3):461-70. PubMed ID: 18804534
    [Abstract] [Full Text] [Related]

  • 2. Immunization with neurofilament light protein induces spastic paresis and axonal degeneration in Biozzi ABH mice.
    Huizinga R, Heijmans N, Schubert P, Gschmeissner S, 't Hart BA, Herrmann H, Amor S.
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):295-304. PubMed ID: 17413320
    [Abstract] [Full Text] [Related]

  • 3. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
    Bannerman PG, Hahn A.
    J Neurol Sci; 2007 Sep 15; 260(1-2):23-32. PubMed ID: 17493638
    [Abstract] [Full Text] [Related]

  • 4. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D, Pham-Dinh D, Reynolds R.
    Exp Neurol; 2006 Feb 15; 197(2):373-85. PubMed ID: 16337942
    [Abstract] [Full Text] [Related]

  • 5. Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Herrero-Herranz E, Pardo LA, Gold R, Linker RA.
    Neurobiol Dis; 2008 May 15; 30(2):162-73. PubMed ID: 18342527
    [Abstract] [Full Text] [Related]

  • 6. T-cell responses to neurofilament light protein are part of the normal immune repertoire.
    Huizinga R, Hintzen RQ, Assink K, van Meurs M, Amor S.
    Int Immunol; 2009 Apr 15; 21(4):433-41. PubMed ID: 19240089
    [Abstract] [Full Text] [Related]

  • 7. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS, Stormanns ER, Bader J, Arnhold S, Addicks K, Kuerten S.
    Clin Immunol; 2013 Oct 15; 149(1):32-45. PubMed ID: 23899992
    [Abstract] [Full Text] [Related]

  • 8. Neuronal NF-κB ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination.
    Lee DH, Kubera K, Rosenthal B, Kaltschmidt B, Kaltschmidt C, Gold R, Linker RA.
    J Neuroimmunol; 2012 May 15; 246(1-2):38-42. PubMed ID: 22475633
    [Abstract] [Full Text] [Related]

  • 9. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 15; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 10. Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice.
    Lev N, Barhum Y, Melamed E, Offen D.
    Neurosci Lett; 2004 Apr 15; 359(3):139-42. PubMed ID: 15050683
    [Abstract] [Full Text] [Related]

  • 11. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis.
    Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, Gerhardt E, Neumann H, Sendtner M, Lühder F, Gold R.
    Brain; 2010 Aug 15; 133(Pt 8):2248-63. PubMed ID: 20826430
    [Abstract] [Full Text] [Related]

  • 12. Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis.
    Huizinga R, van der Star BJ, Kipp M, Jong R, Gerritsen W, Clarner T, Puentes F, Dijkstra CD, van der Valk P, Amor S.
    Glia; 2012 Mar 15; 60(3):422-31. PubMed ID: 22161990
    [Abstract] [Full Text] [Related]

  • 13. Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.
    Puentes F, van der Star BJ, Victor M, Kipp M, Beyer C, Peferoen-Baert R, Ummenthum K, Pryce G, Gerritsen W, Huizinga R, Reijerkerk A, van der Valk P, Baker D, Amor S.
    J Neuroinflammation; 2013 Sep 22; 10():118. PubMed ID: 24053384
    [Abstract] [Full Text] [Related]

  • 14. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA, Smith PA, Blezer E, Delarasse C, Pham-Dinh D, Laman JD, Bauer J, Amor S, 't Hart B.
    J Neuropathol Exp Neurol; 2008 Apr 22; 67(4):326-40. PubMed ID: 18379435
    [Abstract] [Full Text] [Related]

  • 15. Native myelin oligodendrocyte glycoprotein promotes severe chronic neurological disease and demyelination in Biozzi ABH mice.
    Smith PA, Heijmans N, Ouwerling B, Breij EC, Evans N, van Noort JM, Plomp AC, Delarasse C, 't Hart B, Pham-Dinh D, Amor S.
    Eur J Immunol; 2005 Apr 22; 35(4):1311-9. PubMed ID: 15761848
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J, Ban EJ, Chun KH, Wang S, McQualter J, Bernard C, Toh BH, Alderuccio F.
    Autoimmunity; 2008 Aug 22; 41(5):405-13. PubMed ID: 18568646
    [Abstract] [Full Text] [Related]

  • 18. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP, Piddlesden S, Morgan BP, Reynolds R.
    Exp Neurol; 1994 Oct 22; 129(2):299-310. PubMed ID: 7525334
    [Abstract] [Full Text] [Related]

  • 19. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL, Wolak K, Fournier S, David S.
    Glia; 2010 Mar 22; 58(4):434-45. PubMed ID: 19780195
    [Abstract] [Full Text] [Related]

  • 20. Differential patterns of spinal cord pathology induced by MP4, MOG peptide 35-55, and PLP peptide 178-191 in C57BL/6 mice.
    Kuerten S, Gruppe TL, Laurentius LM, Kirch C, Tary-Lehmann M, Lehmann PV, Addicks K.
    APMIS; 2011 Jun 22; 119(6):336-46. PubMed ID: 21569091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.